OpenPV Signal Explorer
FAERS disproportionality dashboard
Reaction

Joint Noise reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 1,914 reports · 67 co-occurring drugs

As of the last recalculation, Joint Noise appears in 1,914 FAERS reports alongside 67 co-occurring drug terms. The strongest observed disproportionality signal is METHYLPREDNISOLONE ACETATE (PRR 40.0).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Methylprednisolone Acetate2940.040.1
Ciprofolxacin16928.128.1
Ciprofloxacin Tablets16928.128.1
Diphenhydramine Hydrochloride Capsule, Liquid Filled5026.126.2
Ciprofloxacin Hydrochloride20826.026.0
Ciprofloxacin19325.325.4
Esomeprazole Magnesium Capsule, Delayed Release3325.125.2
Esomeprazole Magnesium Delayed Release Capsules3325.125.2
Esomeprazole Magnesium Dihydrate3325.025.1
Tranexamic Acid1518.518.5
Vitamin E4817.017.0
Cetirizine Hydrochloride Allergy4616.916.9
Cetirizine Hydrochloride Tablets4616.916.9
Trimethoprim1816.816.8
Levofloxacin8816.616.6
Levofloxacin In 5% Dextrose8816.616.6
Travoprost1316.416.5
Rosuvastatin Calcium4116.216.2
Leflunomide13715.315.3
Duloxetine8614.014.0
Ciprofloxacin Hydrochloride And Hydrocortisone2412.712.7
Upadacitinib8912.412.4
Telmisartan2012.312.3
Abaloparatide3111.611.6
Mometasone1911.411.4
Asfotase Alfa1010.910.9
Esomeprazole5710.310.3
Lisinopril And Hydrochlorothiazide Tablets79.79.7
Clobetasol Propionate Ointment Usp, 0.05%99.59.6
Clobetasol Propionate99.59.5
Naproxen669.49.4
Duloxetine Hydrochloride1499.39.3
Timolol Maleate88.88.8
Cetirizine618.88.8
Tapentadol Hydrochloride268.68.6
Cetiirizine328.38.3
Colchicine208.38.3
Tocilizumab838.28.2
Sitagliptin538.28.2
Progesterone167.77.7
Lisinopril And Hydrochlorothiazide77.57.5
Baclofen577.47.4
Thyroid, Porcine77.27.2
Hydroxychloroquine477.07.0
Aripiprazole Oral266.96.9
Aripiprazole Orally Disintegrating266.96.9
Sulfasalazine486.86.8
Relugolix146.56.5
Tizanidine146.46.4
Ranolazine66.36.3
Brivaracetam56.16.1
Tofacitinib925.65.6
Denosumab1005.65.6
Desoximetasone95.25.2
Icosapent Ethyl45.15.1
Romosozumab-Aqqg64.84.8
Emicizumab54.44.4
Pegvaliase-Pqpz34.04.0
Secukinumab553.83.8
Botulinum Toxin Type A43.53.5
Risankizumab-Rzaa263.53.5
Fluticasone Furoate, Umeclidinium Bromide And Vilanterol Trifenatate123.23.2
Rimegepant Sulfate32.62.6
Enzalutamide132.42.4
Sarilumab52.12.1
Dupilumab691.61.6
Evolocumab181.21.2

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.